CTIC logo

CTI BioPharma (CTIC) Total Assets

Annual Total Assets

$125.92 M
+$53.49 M+73.85%

December 31, 2022

Summary

Performance

1-Year Change

+73.85%

3-Year Change

+172.09%

5-Year Change

+129.43%

15-Year Change

+129.43%

CTIC Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$303.75 M
CTIC annual total assets is currently -58.54% below its historical high of $303.75 million

3-Year Low

$72.43 M
CTIC annual total assets is currently +73.85% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
CTIC previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
CTIC next annual earnings announcement has not yet been scheduled

OtherCTICbalance sheetmetrics:

Annual Current Assets

$99.40 M
CTIC annual total current assets is $99.40 million

Annual Non Current Assets

$26.53 M
CTIC annual long term assets is $26.53 million

Annual Total Liabilities

$143.50 M
CTIC annual total liabilities is $143.50 million

Annual Current Liabilities

$81.13 M
CTIC annual total current liabilities is $81.13 million

Quarterly Total Assets

$112.27 M
-$13.65 M-10.84%

March 31, 2023

Summary

Performance

3-Month Change

-10.84%

1-Year Change

-14.58%

3-Year Change

+27.61%

5-Year Change

-2.98%

CTIC Quarterly Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$323.23 M
CTIC quarterly total assets is currently -65.27% below its historical high of $323.23 million

3-Year Low

$72.43 M
CTIC quarterly total assets is currently +55.00% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
CTIC previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
CTIC next earnings announcement has not yet been scheduled

OtherCTICbalance sheetmetrics:

Quarterly Current Assets

$86.45 M
CTIC quarterly total current assets is $86.45 million

Quarterly Non Current Assets

$25.82 M
CTIC quarterly long term assets is $25.82 million

Quarterly Total Liabilities

$137.62 M
CTIC quarterly total liabilities is $137.62 million

Quarterly Current Liabilities

$68.23 M
CTIC quarterly total current liabilities is $68.23 million

Total Assets Formula

Total Assets = Current Assets + Non-Current Assets

Annual Total Assets

$125.92 M
CTIC annual total assets is $125.92 million

Annual Non Current Assets

$26.53 M
CTIC annual long term assets is $26.53 million

Annual Current Assets

$99.40 M
CTIC annual total current assets is $99.40 million

CTIC Total Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+73.8%-14.6%
3 y3 years+172.1%+27.6%
5 y5 years+129.4%-3.0%

CTIC Total Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high-42.5%-16.5%-35.5%
5 y5-yearat high-63.2%-16.5%-61.9%
alltimeall time-58.5%-75.5%-65.3%-75.1%

CTI BioPharma Total Assets History

DateAnnualQuarterly
Mar 2023
-
$112.27 M(-10.8%)
Dec 2022
$125.92 M(+73.8%)
$125.92 M(+2.0%)
Sep 2022
-
$123.47 M(-8.2%)
Jun 2022
-
$134.53 M(+2.4%)
Mar 2022
-
$131.44 M(+81.5%)
Dec 2021
$72.43 M(+24.4%)
$72.43 M(-28.4%)
Sep 2021
-
$101.23 M(+30.6%)
Jun 2021
-
$77.50 M(+81.1%)
Mar 2021
-
$42.79 M(-26.5%)
Dec 2020
$58.24 M(+25.8%)
$58.24 M(-7.7%)
Sep 2020
-
$63.09 M(-17.4%)
Jun 2020
-
$76.41 M(-13.1%)
Mar 2020
-
$87.98 M(+90.1%)
Dec 2019
$46.28 M(-48.5%)
$46.28 M(-21.0%)
Sep 2019
-
$58.58 M(-11.6%)
Jun 2019
-
$66.24 M(-12.6%)
Mar 2019
-
$75.77 M(-15.7%)
Dec 2018
$89.83 M(+63.7%)
$89.83 M(+0.2%)
Sep 2018
-
$89.63 M(-12.6%)
Jun 2018
-
$102.59 M(-11.4%)
Mar 2018
-
$115.72 M(+110.8%)
Dec 2017
$54.89 M(-14.0%)
$54.89 M(-16.2%)
Sep 2017
-
$65.53 M(-24.1%)
Jun 2017
-
$86.33 M(+93.3%)
Mar 2017
-
$44.66 M(-30.0%)
Dec 2016
$63.84 M(-55.7%)
$63.84 M(-16.5%)
Sep 2016
-
$76.49 M(-21.7%)
Jun 2016
-
$97.63 M(-20.9%)
Mar 2016
-
$123.44 M(-14.4%)
Dec 2015
$144.20 M(+56.2%)
$144.20 M(+128.4%)
Sep 2015
-
$63.13 M(-14.1%)
Jun 2015
-
$73.46 M(+16.5%)
Mar 2015
-
$63.07 M(-31.7%)
Dec 2014
$92.29 M(-1.5%)
$92.29 M(+34.5%)
Sep 2014
-
$68.59 M(+24.1%)
Jun 2014
-
$55.26 M(-24.6%)
Mar 2014
-
$73.29 M(-21.8%)
Dec 2013
$93.72 M(+27.1%)
$93.72 M(+98.4%)
Sep 2013
-
$47.24 M(-4.0%)
Jun 2013
-
$49.23 M(-24.6%)
Mar 2013
-
$65.27 M(-11.5%)
Dec 2012
$73.71 M(+18.4%)
$73.71 M(+103.8%)
Sep 2012
-
$36.17 M(-5.6%)
Jun 2012
-
$38.34 M(-13.2%)
Mar 2012
-
$44.15 M(-29.1%)
Dec 2011
$62.24 M(+16.1%)
$62.24 M(-1.0%)
Sep 2011
-
$62.85 M(+11.1%)
Jun 2011
-
$56.58 M(-7.1%)
Mar 2011
-
$60.92 M(+13.7%)
Dec 2010
$53.59 M(-23.0%)
$53.59 M(+15.0%)
Sep 2010
-
$46.61 M(-50.7%)
Jun 2010
-
$94.58 M(+25.2%)
Mar 2010
-
$75.53 M(+8.5%)
DateAnnualQuarterly
Dec 2009
$69.59 M(+8.3%)
$69.59 M(-20.3%)
Sep 2009
-
$87.30 M(+101.9%)
Jun 2009
-
$43.23 M(+0.7%)
Mar 2009
-
$42.93 M(-33.2%)
Dec 2008
$64.24 M(-12.6%)
$64.24 M(-31.5%)
Sep 2008
-
$93.75 M(-3.2%)
Jun 2008
-
$96.82 M(+23.1%)
Mar 2008
-
$78.64 M(+7.0%)
Dec 2007
$73.51 M(-27.8%)
$73.51 M(-13.5%)
Sep 2007
-
$84.95 M(-5.2%)
Jun 2007
-
$89.58 M(-5.1%)
Mar 2007
-
$94.36 M(-7.3%)
Dec 2006
$101.82 M(-34.5%)
$101.82 M(-15.8%)
Sep 2006
-
$120.99 M(+19.3%)
Jun 2006
-
$101.44 M(-1.8%)
Mar 2006
-
$103.32 M(-33.5%)
Dec 2005
$155.44 M(-16.0%)
$155.44 M(+51.3%)
Sep 2005
-
$102.76 M(+3.0%)
Jun 2005
-
$99.81 M(-29.7%)
Mar 2005
-
$142.01 M(-23.2%)
Dec 2004
$185.00 M(+26.6%)
$185.00 M(+6.2%)
Sep 2004
-
$174.17 M(+7.5%)
Jun 2004
-
$161.94 M(-21.1%)
Mar 2004
-
$205.35 M(+40.6%)
Dec 2003
$146.09 M(-21.8%)
$146.09 M(-16.0%)
Sep 2003
-
$173.85 M(-11.7%)
Jun 2003
-
$196.83 M(+29.8%)
Mar 2003
-
$151.67 M(-18.8%)
Dec 2002
$186.78 M(-38.5%)
$186.78 M(-12.4%)
Sep 2002
-
$213.13 M(-11.7%)
Jun 2002
-
$241.28 M(-14.4%)
Mar 2002
-
$282.00 M(-7.2%)
Dec 2001
$303.75 M(+59.8%)
$303.75 M(-6.0%)
Sep 2001
-
$323.23 M(+3.1%)
Jun 2001
-
$313.49 M(+77.7%)
Mar 2001
-
$176.43 M(-7.2%)
Dec 2000
$190.11 M(+517.2%)
$190.11 M(-4.0%)
Sep 2000
-
$198.02 M(+154.9%)
Jun 2000
-
$77.68 M(-13.9%)
Mar 2000
-
$90.22 M(+192.9%)
Dec 1999
$30.80 M(-47.1%)
$30.80 M(+10.0%)
Sep 1999
-
$28.00 M(-26.7%)
Jun 1999
-
$38.20 M(-19.6%)
Mar 1999
-
$47.50 M(-18.4%)
Dec 1998
$58.20 M(-27.6%)
$58.20 M(-9.9%)
Sep 1998
-
$64.60 M(-5.4%)
Jun 1998
-
$68.30 M(-8.9%)
Mar 1998
-
$75.00 M(-6.7%)
Dec 1997
$80.40 M(+117.3%)
$80.40 M(+55.8%)
Sep 1997
-
$51.60 M(-8.7%)
Jun 1997
-
$56.50 M(-8.9%)
Mar 1997
-
$62.00 M
Dec 1996
$37.00 M
-

FAQ

  • What is CTI BioPharma annual total assets?
  • What is the all time high annual total assets for CTI BioPharma?
  • What is CTI BioPharma annual total assets year-on-year change?
  • What is CTI BioPharma quarterly total assets?
  • What is the all time high quarterly total assets for CTI BioPharma?
  • What is CTI BioPharma quarterly total assets year-on-year change?

What is CTI BioPharma annual total assets?

The current annual total assets of CTIC is $125.92 M

What is the all time high annual total assets for CTI BioPharma?

CTI BioPharma all-time high annual total assets is $303.75 M

What is CTI BioPharma annual total assets year-on-year change?

Over the past year, CTIC annual total assets has changed by +$53.49 M (+73.85%)

What is CTI BioPharma quarterly total assets?

The current quarterly total assets of CTIC is $112.27 M

What is the all time high quarterly total assets for CTI BioPharma?

CTI BioPharma all-time high quarterly total assets is $323.23 M

What is CTI BioPharma quarterly total assets year-on-year change?

Over the past year, CTIC quarterly total assets has changed by -$19.16 M (-14.58%)